Initial studies on an in vivo action spectrum for melanoma induction

被引:14
作者
De Fabo, EC [1 ]
机构
[1] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Environm & Occupat Hlth, Bethesda, MD 20817 USA
关键词
D O I
10.1016/j.pbiomolbio.2006.02.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vitamin D production is initiated by exposure of 7-dehydrocholesterol in the skin to the UVB (280-320 nm) component of sunlight, resulting in the formation of photoproducts, which are subsequently metabolically activated to biologically active moieties in a series of dark reactions as described elsewhere in this Symposium. Irradiation of the skin with UVB has, however, other effects not all of which are beneficial. Most notable is the initiation of skin cancer. Non-melanoma skin cancer is clearly initiated by UVB but for the most lethal of the skin cancers, cutaneous malignant melanoma, although associated with sunlight exposure, the wavelengths responsible have not been clearly identified. Using a mouse model for UV-induced melanoma, we have recently shown that UVB, not UVA (320-400 nm), is also responsible for melanoma initiation. A balance therefore needs to be struck between the healthy effects of exposure to UVB in sunlight-vitamin D formation-and the deleterious effects of which the most potentially serious is melanoma initiation. A powerful tool in determining this balance would be an understanding of the action spectra or wavelength dependence for each of these I effects. Here we describe methodologies, approaches and potential pitfalls for action spectra determination illustrated by our experience with the HGF/SF transgenic mouse model for UV-induced melanoma. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 21 条
[1]  
Armstrong B K, 1997, Australas J Dermatol, V38 Suppl 1, pS1
[2]  
BERWICK M, 2000, FORUM GENOVA, P191
[3]  
Bulliard JL, 2000, INT J CANCER, V85, P627, DOI 10.1002/(SICI)1097-0215(20000301)85:5&lt
[4]  
627::AID-IJC5&gt
[5]  
3.0.CO
[6]  
2-Y
[7]  
Cadet J, 1997, BIOL CHEM, V378, P1275
[8]   Biological action spectra [J].
de Gruijl, FR .
RADIATION PROTECTION DOSIMETRY, 2000, 91 (1-3) :57-63
[9]  
DEFABO E, 1980, BLUE LIGHT SYNDROME, P187
[10]  
DEFABO EC, 1974, ACTION SPECTRUM PHOT, P1